Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity

Keskin, M.; Dolar, MAHMUT; Dirican, MELEHAT; Kiyici, M.; YILMAZ, YUSUF; Gurel, SELİM; Nak, S.; Erdinc, S.; Gulten, M.

doi:10.1111/j.1445-5994.2009.01793.x

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity

Atıf İçin Kopyala

Keskin M., Dolar E., Dirican M., Kiyici M., YILMAZ Y., Gurel S., ...Daha Fazla

INTERNAL MEDICINE JOURNAL, cilt.39, sa.4, ss.243-248, 2009 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 4
Basım Tarihi: 2009
Doi Numarası: 10.1111/j.1445-5994.2009.01793.x
Dergi Adı: INTERNAL MEDICINE JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.243-248
Anahtar Kelimeler: chronic liver disease, liver function tests, paraoxonase, arylesterase, cirrhosis, UREMIC PATIENTS, SERUM, POLYMORPHISM, CIRRHOSIS, DAMAGE
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: It has been recently reported that serum paraoxonase (PON1) and arylesterase (ARE) activities may be significantly reduced in patients with chronic liver disease. The aim of the study was to investigate the relations between serum PON1 and ARE activities and the degree of liver damage in patients with chronic liver injury.